Cancer immunotherapy credit dispute leads to corrections and questions on unfair competition @antonioregalado https://www.technologyreview.com/s/601027/t-cell-pioneer-carl-june-acknowledges-key-ingredient-wasnt-his/ …
0 replies
1 retweet
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.